Month: August 2024

CALGARY, Alberta, Aug. 07, 2024 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (“Wilmington” or the “Corporation”) reported a net loss for the three months ended June 30, 2024, of ($0.1) million or ($0.01) per share and net income for the six months ended June 30, 2024, of $1.1 million or $0.08 per share. compared to net income of $0.7 million or $0.06 per share and $0.1 million and $0.01 per share for the same periods in 2023. A summary of the Corporation’s activities and the operations of its investees is set out below: OverviewDuring the past 12 months the Corporation has monetized a number of its investments in order to unlock the embedded value, which had been substantially realized, simplify its business, repatriate capital to its shareholders and pursue transactions better suited to a changing economic environment. On...

Dallas, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $7.9 million, or $.16 per share, in the second quarter of 2024 compared to a net loss attributable to NL stockholders of $3.1 million, or $.06 per share, in the second quarter of 2023. NL results include an unrealized gain of $.8 million in the second quarter of 2024 related to the change in value of marketable equity securities compared to an unrealized loss of $5.4 million in the second quarter of 2023. For the first six months of 2024, NL reported net income attributable to NL stockholders of $14.7 million, or $.30 per share, compared to a net loss attributable to NL stockholders of $9.8 million, or $.20 per share for the first six months of 2023. NL results include an unrealized gain of...

Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and cash equivalents of $101.5 million as of June 30, 2024 PHILADELPHIA, Aug. 07, 2024 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the second quarter ended June 30, 2024, and reported on recent business highlights. “Context continues to build momentum, and we believe the Company is well positioned to have a successful year,” said Martin Lehr, CEO of Context. “Our team recently initiated our Phase 1 trial for CTIM-76, a Claudin 6 x CD3 bispecific antibody and looks forward to dosing our first patient in the third quarter. In addition, the recent acquisition...

HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its second quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Thursday, August 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10189702/fca6e74d6e. A recording of the webcast will be posted on the Investor Relations section of the company’s...

Dallas, TX, Aug. 07, 2024 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of $19.5 million, or $.17 per share, in the second quarter of 2024 compared to a net loss of $8.2 million, or $.07 per share, in the second quarter of 2023. For the first six months of 2024, Kronos Worldwide reported net income of $27.6 million, or $.24 per share, compared to a net loss of $23.4 million, or $.20 per share, in the first six months of 2023. Net income increased in the 2024 periods as compared to the same periods in 2023 primarily due to higher income from operations as a result of the effects of higher sales and production volumes, lower production costs (primarily energy and raw materials), partially offset by lower average TiO2 selling prices. Our results of operations in the first six months of 2023 were significantly...

Higher Occupancy and Cost Management Initiatives Drive PositiveQuarterly Financial Performance BRENTWOOD, Tenn., Aug. 07, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its second quarter 2024 financial results.   Financial Highlights – Second Quarter 2024Total revenue of $490.1 millionCoreCivic Safety revenue of $455.4 million CoreCivic Community revenue of $30.3 million CoreCivic Properties revenue of $4.4 millionNet income of $19.0 million; Adjusted Net Income of $21.8 million Diluted earnings per share of $0.17; Adjusted Diluted EPS of $0.20 Normalized FFO per diluted share of $0.42, an increase of 27% Adjusted EBITDA of $83.9 million, an increase of 16%Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, commented, “CoreCivic carried its...

– Q3 Orders increase 46% to $312 million / Book-to-Bill of 1.20x – Q3 Sales increase 5% to $261 million – Q3 GAAP EPS increases 5% to $1.13 – Q3 Adjusted EPS increases 6% to $1.16 – St. Louis, Aug. 07, 2024 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the third quarter ended June 30, 2024 (Q3 2024). Operating HighlightsQ3 2024 Sales increased $12.1 million (5 percent) to $260.8 million compared to $248.7 million in Q3 2023. Q3 organic sales increased $8.7 million (4 percent) and the MPE acquisition contributed $3.4 million (1 percent) of revenue in the quarter.    Q3 2024 GAAP EPS increased 5 percent to $1.13 per share compared to $1.08 per share in Q3 2023. Q3 2024 Adjusted EPS increased 6 percent to $1.16 per share compared...

Allentown. PA, Aug. 07, 2024 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Second Quarter 2024 ResultsReported Second Quarter 2024 Net Income of $12.4 million, Adjusted EBITDA of $42.6 million and Distributable Cash Flow of $26.1 million compared to Net Income of $14.5 million, Adjusted EBITDA of $42.2 million and Distributable Cash Flow of $30.4 million for the Second Quarter 2023 Reported Second Quarter 2024 Gross Profit for the Retail Segment of $76.6 million compared to $66.0 million of Gross Profit for the Second Quarter 2023 and Second Quarter 2024 Gross Profit for the Wholesale Segment of $28.1 million compared to $31.7 million of Gross Profit for the Second Quarter 2023 Leverage, as defined in the CAPL Credit Facility, was 4.39 times as of June 30, 2024, compared to 4.49 times as of March 31, 2024 The Distribution...

COLUMBUS, Ohio, Aug. 07, 2024 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, announced financial results for the quarter today. Root’s second quarter financial results and management commentary can be found by accessing the shareholder letter posted to the company’s investor relations website. An updated version of the company’s investor presentation will also be available. Both can be found on ir.joinroot.com. Root will host a conference call and earnings webcast to discuss the results and provide an update on company operations today, Wednesday, August 7, at 5:00 p.m. Eastern Time. To listen to the live audio webcast, please visit the News & Events section of Root’s Investor Relations website at ir.joinroot.com. Webcast and Conference Call Details: Date: August 7, 2024Time: 5:00...